Amunix Pharmaceuticals Inc., of Mountain View, Calif., appointed Anne Keane senior vice president of regulatory and quality.
Arcus Biosciences Inc., of Hayward, Calif., appointed David Lacey to its board.
Assembly Biosciences Inc., of South San Francisco, appointed William Delaney chief scientific officer.
Brainstorm Cell Therapeutics Inc., of New York, appointed Stacy R. Lindborg executive vice president, head of global clinical research, effective June 1, 2020.
Corbus Pharmaceuticals Holdings Inc., of Norwood, Mass., appointed John Amedio Jr. vice president and head of CMC development and commercial manufacturing.
Evox Therapeutics Ltd., of Oxford, U.K., appointed Martin Andrews to its board.
Kinnate Biopharma Inc., of San Diego, appointed Nima Farzan CEO and board member. The company also named Stephen Kaldor chair of its board and Mark Meltz chief operating officer and general counsel.
Matrisys Bioscience Inc., of San Diego, appointed Magda Marquet chair of its board.
TCR2 Therapeutics Inc., of Cambridge, Mass., appointed Gregg McConnell head of business development and Viera Muzithras vice president of regulatory affairs.
Urovant Sciences Inc., of Irvine, Calif., and Basel, Switzerland, appointed Jim Hindman to its board.